Revolutionizing Patient Care with MyBreathPrint
When you’re facing a cancer diagnosis or awaiting the results of your latest scan, every hour may feel like an eternity. From the moment you know something is off, you may feel like you’re constantly waiting for the next steps — the next appointment with a specialist, the next scan, the next test result, the next step in your treatment plan. You just want to know!
Every year, families, friends, neighbors, entire communities go through the painful cancer journey with a loved one. For example, 47 percent of lung cancer patients are not detected until a late stage when the survival rate is only six percent. MyBreathPrint® was created to eliminate late-stage diagnosis and save millions of lives through regular noninvasive health status screenings…so you know!
Waiting is stressful! MyBreathPrint has the potential to make health screenings as simple and noninvasive as breathing, removing many of the barriers that keep people from pursuing regular screenings: inconvenience, access and fear. Knowledge is power, and it can also be lifesaving.
TODAY ALONE, 5,200 PEOPLE IN THE UNITED STATES WILL BE DIAGNOSED WITH CANCER.
LUNG CANCER IS THE LEADING CAUSE OF CANCER DEATH WORLDWIDE
In 2023, an estimated 238,340 people were diagnosed with lung cancer in the US.
EARLY DETECTION INCREASES SURVIVABILITY BY 10 TIMES
A lung cancer diagnosis at a late stage drastically decreases 5-year survivability to only 5%.
1 IN 16 AMERICANS WILL BE DIAGNOSED WITH LUNG CANCER IN THEIR LIFETIME
60-65% of new lung cancer diagnoses are people who never smoked or are former smokers.
LUNG CANCER COSTS $50B TO THE US ECONOMY ANNUALLY
Lung cancer costs $13B-plus to the US, and $36B-plus is in lost productivity annually.
Why MyBreathPrint
1
NONINVASIVE Discovering whether you have lung cancer or not can take vital time and is ultimately surgically invasive and not without risk. MyBreathPrint reads the volatile organic compound (VOC) pattern of disease on your breath. No needles, no radiation, no surgery. And no waiting!
2
ACCESSIBLE The MyBreathPrint system is mobile and connected, so whether you’re at home or in your doctor’s office, your BreathPrint® will be delivered to your doctor in seconds. You’ll know your health status as soon as you communicate with your doctor.
3
ACCURATE Our inventive array of sensors is sensitive enough to detect the VOCs found in human breath, and with leading-edge data science techniques, analyze the patterns of thousands of VOCs to generate your unique BreathPrint and ascertain your health.
4
BETTER OUTCOMES Early detection of cancer can mean less extensive treatment, more treatment options and better chances of survival. It also reduces the risk of complications, improving long-term health outcomes.
5
COST-EFFECTIVE Regular screenings with MyBreathPrint are considerably more cost-effective than a low-dose CT scan. And when you consider the expense of more aggressive treatments when cancer is detected in its late stages, the cost impact is exponential.
Waiting vs. Knowing
Wait-and-see Protocols Versus MyBreathPrint
The cancer journey typically begins with an observation…a shadow, a lump, a symptom. After that initial realization that there is something concerning, a patient can spend much of their time waiting for answers. Anxiety, fear, dread are all common as you proceed through the diagnosis and then the treatment journey. While Vocxi Health cannot alleviate all the pain and dread, MyBreathPrint was created to quickly, immediately, noninvasively provide an answer: cancer or not cancer.
watchful waiting
The Current Lung Cancer Diagnosis Journey
Identification
In most cases, lung cancer symptoms are not easily identified until an advanced stage. Sometimes nodules are discovered accidentally through an X-ray or CT scan while looking for something else. Those at high risk for lung cancer can discuss regular screenings with their doctor.
screening
If you have symptoms or an identified nodule, a low-dose CT scan is performed. Depending on your risk level, you return every three months to monitor changes in the nodule’s size or shape . If you are high risk for lung cancer with no symptoms or identified nodules, screening is typically annual.
biopsy
Whether you have symptoms and/or an identified nodule, to determine if it is cancerous or non-cancerous, lung tissue samples are removed with a special biopsy needle or with surgery, depending on the nodule’s location. Wait times for biopsy are dependent upon schedule and accessibility.
results
The results of a lung biopsy can take a week or two after the procedure. Biopsies can tell your doctor if the abnormal tissue is cancerous or non-cancerous. If it is cancer, a biopsy can also identify the cancer’s severity and grade.
Knowing vs. Waiting
MyBreathPrint Diagnosis Journey
BREATHE
At your doctor’s office (or eventually from home) you breathe normally into the MyBreathPrint device for one minute.
analyze
The data is instantly sent to the cloud-based platform to develop your unique BreathPrint.
results
Your results are immediately sent to your doctor who will communicate with you about your health status.
A 2022 report from the American Lung Association indicated that only 5.8% of Americans had been screened for lung cancer and that in some states, rates were as low as 1%.
cost savings
Lung cancer costs the US economy $50B and the global economy $3.9T.
life savings
Millions of years of life are saved through regular screenings using mammograms, Pap tests, colonoscopies and CTs scans.
accessibility
Barriers to screening included fear, low-perceived risk and practical barriers of cost, travel and time off work.
Lung Cancer & Beyond
Future Applications
With one hardware design, MyBreathPrint is scalable and, through its machine learning platform, customizable to detect a wide variety of diseases and ailments.
other cancers
infectious diseases
emergency medicine
A Breath-through Solution
Innovating with Human Breath Intelligence
The breakthrough of MyBreathPrint to detect disease early, immediately and noninvasively is at the intersection of nanotechnology, chemistry and machine learning.
WHAT ARE VOCS?
Volatile Organic Compounds are gaseous molecules that can originate from within the body or externally.
PARTNER WITH
VOCXI
Be a part of the Vocxi mission and help us bring MyBreathPrint to millions of patients worldwide!
